Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Shattuck Labs, Inc.STTK · Entity 5224 | General Counsel | January 25, 2023 | January 27, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Shattuck Labs, Inc.
Report date January 25, 2023 · Filed January 27, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 103,209 |
Reported balance
After 2023-01-25 transaction · row 1
1 source rowRow 1 · 2023-01-25 · Grant · Acquired 24,125 · Balance 103,209 F1: Consists of 24,125 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.57 · Expires 2033-01-25 | Direct | 48,250 |
Reported balance
After 2023-01-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-25 · Grant · Acquired 48,250 · Balance 48,250 F2: This option represents a right to purchase a total of 48,250 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 24,125 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer.
F2: This option represents a right to purchase a total of 48,250 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 25, 2023 Filed Jan 27, 2023 23:11 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | GrantStock Option (Right to Buy) · Derivative | 48,250 | $0.00 Strike: $3.57 | $0.00 |
DisclosureSEC source: 0000899243-23-002889 · doc4.xml · derivative · entry 2 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,250 Underlying: Common Stock · 48,250 shares Expires 2033-01-25 F2 · derivative.exercise_date: This option represents a right to purchase a total of 48,250 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:11 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | GrantCommon Stock | 24,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002889 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,209 F1 · shares: Consists of 24,125 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 12, 2022 Filed Jan 12, 2022 23:39 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0000899243-22-001791 · doc4.xml · derivative · entry 4 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,705 Underlying: Common Stock · 10,000 shares Expires 2028-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option represents the right to purchase a total of 63,705 shares of the Issuer's common stock, 15,925 of which vested on May 15, 2019, with the remaining shares vesting in equal monthly installments through May 15, 2022. Read SEC document |
| January 12, 2022 Filed Jan 12, 2022 23:39 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | Exercise / conversionCommon Stock | 10,000 | $2.95 | $29,500.00 |
DisclosureSEC source: 0000899243-22-001791 · doc4.xml · nonDerivative · entry 2 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 23:39 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | GrantStock Option (Right to Buy) · Derivative | 45,650 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0000899243-22-001791 · doc4.xml · derivative · entry 3 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,650 Underlying: Common Stock · 45,650 shares Expires 2032-01-10 F2 · derivative.exercise_date: This option represented a right to purchase a total of 45,650 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2023, with the remaining three quarters vesting in equal monthly installments through January 10, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 23:39 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | GrantCommon Stock | 22,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001791 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,084 F1 · shares: Consists of 22,825 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 22:10 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | SaleCommon Stock | 33,000 | $19.50 | $643,500.00 |
DisclosureSEC source: 0000899243-21-040994 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,259 F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 21:03 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | SaleCommon Stock | 2,000 | $22.18 | $44,366.80 |
DisclosureSEC source: 0000899243-21-028670 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,259 F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $21.475 to $22.95. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 18, 2021 Filed Jun 23, 2021 00:11 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | SaleCommon Stock | 3,000 | $30.00 | $90,000.00 |
DisclosureSEC source: 0000899243-21-025424 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,259 F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 23:25 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | SaleCommon Stock | 4,000 | $27.55 | $110,219.20 |
DisclosureSEC source: 0000899243-21-024258 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,259 F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $27.08 to $28.55. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2021 Filed Jun 8, 2021 23:39 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | SaleCommon Stock | 3,000 | $30.00 | $90,000.00 |
DisclosureSEC source: 0000899243-21-022645 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,259 F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 17, 2021 Filed May 18, 2021 01:10 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | SaleCommon Stock | 4,000 | $26.25 | $104,981.60 |
DisclosureSEC source: 0000899243-21-019688 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,259 F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $25.91 to $26.61. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 21:00 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | SaleCommon Stock | 5,000 | $35.00 | $175,000.00 |
DisclosureSEC source: 0000899243-21-017649 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,259 F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 22:12 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | SaleCommon Stock | 7,000 | $30.77 | $215,390.00 |
DisclosureSEC source: 0000899243-21-016247 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,259 F1 · price: This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $29.72 to $33.03. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 22:00 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | GrantStock Option (Right to Buy) · Derivative | 14,608 | $0.00 Strike: $53.02 | $0.00 |
DisclosureSEC source: 0000899243-20-035214 · doc4.xml · derivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,608 Underlying: Common Stock · 14,608 shares Expires 2030-12-22 F1 · derivative.exercise_date: This option represents a right to purchase a total of 14,608 shares of the Issuer's common stock, one quarter of which will vest on December 22, 2021, with the remaining three quarters vesting in equal monthly installments through December 22, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:30 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,952 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0000899243-20-030628 · doc4.xml · derivative · entry 2 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,952 shares Expires 2027-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the shares of the Issuer's common stock underlying this option are vested and exercisable as of the date hereof. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:30 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | Exercise / conversionCommon Stock | 2,952 | $0.01 | $29.52 |
DisclosureSEC source: 0000899243-20-030628 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 21:27 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | ConversionSeries A Preferred Stock · Derivative | 160 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028346 · doc4.xml · derivative · entry 2 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,096 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering and had no expiration date. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 21:27 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | ConversionCommon Stock | 1,096 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-028346 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering and had no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.